U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales 
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion 
Google Seeks Delay on Data-Sharing Order as It Appeals Landmark Antitrust Ruling 
Taiwan Issues Arrest Warrant for OnePlus CEO Over Alleged Illegal Recruitment Activities 
California Attorney General Orders xAI to Halt Illegal Grok Deepfake Imagery 
U.S. Transportation Board Sends Union Pacific–Norfolk Southern Merger Back for Revision 
Rio Tinto and BHP Agree to Explore Major Iron Ore Collaboration in Pilbara 
Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement 
Toyota Industries Buyout Faces Resistance as Elliott Rejects Higher Offer 
Chevron Set to Expand Venezuela Operations as U.S. Signals Shift on Oil Sanctions 
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft 
Walmart International CEO Kathryn McLay to Step Down After Two and a Half Years 
China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production 
China’s AI Models Narrow the Gap With the West, Says Google DeepMind CEO 
Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation 
TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure 
Boeing Reaches Tentative Labor Deal With SPEEA Workers After Spirit AeroSystems Acquisition 
VANCOUVER, Washington, April 06, 2017 -- CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of new antibody therapies for combating human immunodeficiency virus (HIV) infection, announces that management will hold an investment community conference call on Tuesday, April 18, 2017, at 1:00 p.m. PT / 4:00 p.m. ET to provide an update on clinical trial and regulatory developments.
Conference Call and Webcast Instructions
Interested participants and investors may access this conference call by dialing 877-407-2986 (U.S./Canada) or 201-378-4916 (international).
A live audio webcast may also be accessed via CytoDyn’s corporate website at www.cytodyn.com under the Investors section/IR Calendar and will be archived for 60 days. Web participants are encouraged to go to the website 15 minutes prior to the start of the call to register, download and install any necessary software. The webcast can also be accessed via the following link:
http://cytodyn.equisolvewebcast.com/4-18-17.
A replay of the conference call will be available until June 18, 2017. To access the replay, interested parties may dial 877-660-6853 (U.S./Canada) or 201-612-7415 (international); Conference ID: 13652328.
CONTACTS: Investors: LHA Jody Cain Office: 310-691-7100 E-mail: [email protected] Media: Nader Pourhassan, Ph.D. President & CEO Office: 360-980-8524 Email: [email protected]
